Vanguard Health Care Index Fund ETF Shares VHT
341.23 USD +0.03 (+0.01%)
At closeNov 6, 2026, 5:27 PM EST
341.23 0.00 0.00%
After hours · Nov 6, 5:27 PM ET
334.76 Day range 343.08
265.36 52-week range 351.23
- YTD
- +18.54%
- 1 year
- +25.35%
News
benzinga.com UnitedHealth Raises Guidance: What It Means for XLV and Other Healthcare ETFs UnitedHealth raises its 2026 earnings outlook after beating Q3 estimates. Compare XLV, IHF and VHT for UNH exposure.
benzinga.com Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.
benzinga.com Hotter PCE Inflation: 5 Defensive ETFs Investors Can Turn to as Rate-Cut Hopes Fade Hotter-than-expected inflation could keep rates higher. These ETFs offer potentially steadier exposure amid persistent price pressures.
benzinga.com Justin Wolfers Warns of a 'Pink Collar' Economy Amid July Jobs Report: 'If You Don't Wear Scrubs… You're Losing Jobs' Economist Justin Wolfers warns of a 'pink collar' economy as the U.S. sheds 23,000 jobs in July, with only the healthcare sector hiring.
benzinga.com UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
benzinga.com The Cerebras IPO Is Tomorrow — And Markets Are Flashing A Major Sell Signal A euphoric market rallies on narrowing leadership, extreme upside volatility and AI‑driven concentration, even as weak deployment, speculative IPOs and rising fragility echo late‑cycle patterns.
benzinga.com White House Reportedly Preparing To Oust FDA Commissioner Marty Makary Trump considers Kyle Diamantas for acting FDA chief as Marty Makary faces potential removal. Stay updated on the leadership transition.
benzinga.com S&P 500's Best‑Kept Secret: Why Healthcare Could Be 2026's Breakout Winner AI‑powered drug discovery, strong earnings upgrades, and rising institutional flows show why healthcare may shift from 2026 laggard to breakout S&P 500 growth story.
benzinga.com Humana, UnitedHealth Stocks Pop After Medicare Surprise — ETFs In Focus A Medicare policy boost sends UnitedHealth stock and Humana higher, with ETFs emerging as key beneficiaries.
benzinga.com Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes Ahead of April, also the autism acceptance month, Defiance filed for a biopharma ETF with a pledge to donate profits to autism services and research.
benzinga.com Jobs Report Just Dented Most Bulletproof Sector ETF In The Market A weak U.S. jobs report hit health care employment, raising questions about the resilience of the sector and the outlook for healthcare ETFs.
benzinga.com Stocks May Survive War — But What Happens To ETFs At $120 Oil? Middle East tensions may not derail stocks — but a sustained oil spike could. Here's how ETFs are positioning around the real risk: crude.
benzinga.com UnitedHealth Flags Margin Stress, Pushing Investors Toward Broader Healthcare ETFs UNH earnings reveal rising margin pressure from Medicare Advantage; investors may look to these healthcare ETFs for diversification.
benzinga.com 7 ETF Themes Investors Are Watching As The Fear & Greed Index Slips Toward Caution U.S. stocks slid as trade tensions rose and the Fear & Greed Index turned neutral, turning the spotlight on defensive, dividend, and low-volatility ETFs.
benzinga.com As AI Valuations Stretch, Health Care ETFs Step Into The Growth Spotlight Health care ETFs are positioned to benefit this year from weight-loss drug growth and defensive appeal as investors rotate away from AI stocks.
benzinga.com Novo Nordisk's Wegovy Pill Shakes Up Rivalry With Eli Lilly, Puts Health Care ETFs In Focus Novo Nordisk's FDA-approved weight-loss pill intensifies its rivalry with Eli Lilly, putting health care and biotech ETFs in focus.
benzinga.com Why Health Care ETFs Aren't Panicking Over Big Pharma's Price Cuts Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.
benzinga.com Healthcare ETFs Trounce Tech, Grab Billions As Big Money Flees Bubble Fears Healthcare ETFs are raking in fresh inflows while tech bleeds, reflecting a defensive shift as investors grow wary of frothy valuations.
benzinga.com Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.
benzinga.com How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline Trump's comments on health-care negotiations with Democrats can put ETFs like XLV, IHF, and XHS back on investors' radar as Washington's shutdown drags on.
benzinga.com Trump Admin Targets Medicaid Spending On Immigrants, Threatening Over $12 Billion California Program The Trump administration is investigating Medicaid spending in California and other Democrat-led states over potential misuse in immigrant healthcare programs.
benzinga.com RFK Jr.'s Massive Federal Health Workforce Cut Could Take 'Decades To Rebuild,' Warn Experts: 'We Cannot Accurately Assess Whether We Are Truly Making America Healthier' Experts raise alarms about Health Secretary Robert F. Kennedy Jr's decision to layoff tens of thousands of federal workers, disrupting critical health data collection and research efforts.
benzinga.com As Trump Tariffs Spark Panic, Investors Rush Into These 5 'Recession-Proof' ETFs ETFs that provide exposure to sectors that have historically been considered defensive during downturns are now in the limelight.
benzinga.com NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst Robert F. Kennedy Jr.'s appointment as Secretary of Health and Human Services has sparked concerns over funding for the NIH.
benzinga.com US States Sue National Institutes Of Health Over $4 Billion Annual Cut In Biomedical Research Grant Budget A federal judge halted NIH's plan to cap indirect grant costs at 15%, citing potential harm to research. A hearing is set for February 21.
benzinga.com Goldman Sachs Predicts Gradual Recovery For Tools And Contract Research Sector In 2025, Stable Large Pharma Spending Key To Recovery Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.
benzinga.com S&P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge The year of milestones, 2024, has seen an unperturbed rise in the bull market, we recap 2024's landmark junctures in the U.S. stock market.
benzinga.com Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
benzinga.com FDA Commissioner Califf Candid on Trump's Impact: 'We Just Don't Know What's Going to Happen' FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and highlighting uncertainty within the agency.
benzinga.com Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024 According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.- benzinga.com S&P 500 Stuck In 4,600-4,800 Limbo For 2024? Wells Fargo Pinpoints 3 'Favored Sectors' For Next Year Wells Fargo Investment Institute has a 4600-4800 year-end 2024 target for the S&P 500 Index and 2000-2200 for the MSCI EAFE Index. Favored sectors are Health Care, Industrials, and Materials.
benzinga.com Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups A proposed regulatory shift has injected uncertainty into the laboratory-testing market just as startups advance various tests to detect diseases sooner and personalize treatments.
benzinga.com From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as…- benzinga.com Heaps Of Healthy Health Care ETFs
- benzinga.com Vanguard Has Its Say In ETF Fee War
benzinga.com Government Study: Cellphone Radiation Linked To Cancer - benzinga.com Vanguard Is At It Again; Lowers Fees On 21 ETFs
- benzinga.com Write A Prescription For Health Care ETFs
benzinga.com Don't Forget About This Small-Cap Health Care ETF - benzinga.com Health Care ETFs Looking Healthy Ahead of Earnings
- benzinga.com 4 Health Care ETFs Your Broker Forgot to Mention
- benzinga.com Vanguard Trims Fees on Sector ETFs
- benzinga.com ETFs to Watch November 3, 2011
benzinga.com Fifteen Health Care ETFs Trading Near 52-Week Highs - benzinga.com Twelve Health Care ETFs Trading Near 52-Week Highs
- benzinga.com Still Ignored, Still Outperforming